SODIUM FLUORIDE 1.1% AND POTASSIUM NITRATE 5% DENTAL GEL

Manufacturer
Sheffield Pharmaceuticals LLC
Effective date
2020-04-01
Label type
Human Prescription Drug Label
Version
2
Source
full-release
Hydrated at
2026-05-31 20:32:37

Label at a glance#

ProductSodium Fluoride 5000 ppm Sensitive
Active ingredientSODIUM FLUORIDE, POTASSIUM NITRATE
Label structure16 sections

Indications and uses

A dental caries preventive and sensitive toothpaste; for twice daily self-applied topical use,following by rinsing, helps reduce the painful sensitivity of the teeth to cold, heat, acid, sweets or contact in adults patients and children 12 years of age and older.  It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece ap...

Dosage and administration

Follow these instructions unless otherwise instructed by your dental professional: Adults and pediatric patients 12 years of age or older, apply at least a 1 inch strip of Sodium Fluoride 5000 ppm Sensitive onto a soft bristle toothbrush. Brush teeth thoroughly for at least 1 minute, expectorate, and rinse mouth thoroughly.   Use twice daily, (morning and evening) or as recommended by dentist or physician. Make su...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

SODIUM FLUORIDE 5000 ppm Sensitive toothpaste 

Rx ONLY

DESCRIPTION:

DESCRIPTION SECTION

Self-topical neutral fluoride toothpaste containing 1.1% (w/w) sodium fluoride and 5% potassium nitrate.  

Active Ingredients:

SPL UNCLASSIFIED SECTION

Sodium Fluoride 1.1% (w/w) 

Potassium Nitrate 5% 

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

Blue 1,  Carrageenan, Cocamidopropyl Betaine, Flavor, Hydrated Silica, Mica, PEG-12, Poloxamer 407, Sodium Hydroxide, Sodium Laurryl Sulfate, Sodium Saccharin, Sorbitol, Titanium Dioxide, Water (purified), Yellow 10 

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into tooth enamel.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

A dental caries preventive and sensitive toothpaste; for twice daily self-applied topical use,following by rinsing, helps reduce the painful sensitivity of the teeth to cold, heat, acid, sweets or contact in adults patients and children 12 years of age and older.  It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4 Sodium Fluoride 5000 ppm Sensitive 1.1% sodium fluoride toothpaste with 5% potassium nitrate in a squeeze-tube is easily applied onto a toothbrush. This prescription toothpaste should be used twice daily in place of your regular toothpaste, unless otherwise instructed by your dental professional. May be used whether or not drinking water is fluoridated, since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Do not use in pediatric patients under age 12 years unless recommended by a dentist or physician.

WARNINGS:

WARNINGS SECTION

Not for systemic treatment- Do not Swallow. Keep out of the reach of children.  Children under 12 years of age, consult a dentist or physician. Note: Sensitive teeth may indicate a serious problem that may need prompt care by a dentist. See your dentist if the problem persists or worsens. Do not use this product longer than 4 weeks unless recommended by a dentist or physician. 

PRECAUTIONS:

PRECAUTIONS SECTION

General not for systemic treatment. DO NOT SWALLOW.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer. Fluoride ion is not mutagenic in standard bacterial systems. It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. In vivo data are conflicting. Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results. Potential adverse reproductive effects of fluoride exposure in humans have not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.

Pregnancy:

PREGNANCY SECTION

Teratogenic Effects Pregnancy Category B. It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. There are no adequate and well-controlled studies in pregnant women. However, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis, which becomes evident in childhood.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.

Pediatric Use:

PEDIATRIC USE SECTION

 Safety and effectiveness in pediatric patients below the age of 12 years have not been established. Please refer to the CONTRAINDICATIONS and WARNINGS sections.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Allergic reactions and other idiosyncrasies have been rarely reported. To report SUSPECTED ADVERSE REACTIONS, contact Sheffield Pharmaceuticals, LLC. at 1-800-222-1087 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

OVERDOSAGE:

OVERDOSAGE SECTION

Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nausea, vomitting, and diarrhea may occur soon after ingestion (within 30 minutes)and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (i.e. less than 2.3 mg fluoride/lb body weight) have been ingested, give calcium (e.g.milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (i.e. more than 2.3 mg fluoride/lb body weight) have been ingested, induce vomitting, give orally soluble calcium (e.g. milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride /kg of body weight (i.e. more than 6.9 mg fluoride/lb body weight), induce vomitting and admit immediately to a hospital facility. A treatment dose (a thin ribbon) of Sodium Fluoride 5000 ppm Sensitive contains approximately 2.5 mg fluoride. A 3.4 FLOZ (100 ml) tube contains approximately 575 mg fluoride.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Follow these instructions unless otherwise instructed by your dental professional:

  1. Adults and pediatric patients 12 years of age or older, apply at least a 1 inch strip of Sodium Fluoride 5000 ppm Sensitive onto a soft bristle toothbrush. Brush teeth thoroughly for at least 1 minute, expectorate, and rinse mouth thoroughly.  
  2. Use twice daily, (morning and evening) or as recommended by dentist or physician. Make sure to brush all sensitive areas of the teeth. Children under 12 years of age:consultant a dentist or physician.  

HOW SUPPLIED SECTION

HOW SUPPLIED:Mild Mint 
3.4 floz. (100ml) net wt. tubeNDC# 11527-704-42

STORAGE:

STORAGE AND HANDLING SECTION

Store at Controlled Room Temperature, 20-25°C (68-77°F).

REFERENCES:

REFERENCES SECTION

  1. American Dental Association, Accepted Dental Therapeutics, Ed. 40, Chicago, ADA, 405-407(1984).
  2. H.R. Englander et al., JADA, 75, 638-644 (1967).
  3. H.R. Englander et al., JADA, 78, 783-787 (1969).
  4. H.R. Englander et al., JADA, 82, 354-358 (1971).

PRINCIPAL DISPLAY PANEL - 100ml Tube

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Wentworth                               NDC 11527-704-42

Sodium Fluoride 5000 ppm         MILD MINT

Sensitive 

1.1% Sodium Fluoride, 5% Potassium Nitrate 

Prescription Strength toothpaste for Sensitive Teeth 

3.4 FLOZ (100ml)                        Rx only 

Wentworth Sensitive Tube.jpgWentworth Sensitive Tube.jpg

PRINCIPAL DISPLAY PANEL - 100 ml Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Wentworth                           NDC 11527-704-42

Sodium Fluoride 5000 ppm       MILD MINT 

Sensitive 

1.1% Sodium Fluoride, 5% Potassium Nitrate 

Prescription Strength toothpaste for Sensitive teeth 

3.4 FLOZ (100ml)                         Rx only

544198-SH00145_Sensitve_Carton.jpg544198-SH00145_Sensitve_Carton.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
6084a4f4-5437-c9a5-caec-5361ee075a59Product name120140508
90c5639a-61b0-88d6-ddcf-21888e94869aProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11527-704-42Sodium Fluoride 5000 ppm Sensitive100 mL in 1 TUBEGEL, DENTIFRICE1002
11527-704-42Sodium Fluoride 5000 ppm Sensitive1 in 1 CARTONGEL, DENTIFRICE12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11527-704SODIUM FLUORIDE 5000 PPM SENSITIVE (SODIUM FLUORIDE1.1%, POTASSIUM NITRATE 5%) GEL, DENTIFRICE [SHEFFIELD PHARMACEUTICALS LLC]2Current NDC, Legacy NDC, 2 package rows20200402_02f4cf0b-188c-4522-b759-ffe4a9d150e8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11527-704-42ML - Milliliter11527-7047c9bcb17-6db0-43d2-ad53-1bfcfcbcf78012020-07-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11527-70411527-704-42

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Fluoride 5000 ppm SensitiveSODIUM FLUORIDE1.1%, POTASSIUM NITRATE 5%Sheffield Pharmaceuticals LLC02f4cf0b-188c-4522-b759-ffe4a9d150e82020-04-01Warnings, Adverse reactionsExact identifier
ndc (package): 11527-704-42
ndc (product): 11527-704
ndc11 (package): 11527070442
spl id: c850c90a-b9bc-44b7-b30c-3f297f3ae164
spl set id: 02f4cf0b-188c-4522-b759-ffe4a9d150e8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.